News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,428 Results
Type
Article (17638)
Company Profile (120)
Press Release (165670)
Section
Business (58277)
Career Advice (944)
Deals (9372)
Drug Delivery (36)
Drug Development (23459)
Employer Resources (72)
FDA (2357)
Job Trends (4252)
News (92332)
Policy (5792)
Tag
2024 BioCapital Digital (3)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (485)
Accelerated approval (1)
Adcomms (13)
Allergies (21)
Alliances (16227)
ALS (34)
Alzheimer's disease (439)
Antibody-drug conjugate (ADC) (79)
Approvals (2325)
Artificial intelligence (101)
Autoimmune disease (9)
Automation (4)
Bankruptcy (85)
Best Places to Work (2896)
BIOSECURE Act (18)
Biosimilars (27)
Biotechnology (111)
Bladder cancer (26)
Brain cancer (14)
Breast cancer (81)
Cancer (808)
Cardiovascular disease (56)
Career advice (761)
Career pathing (20)
CAR-T (94)
Cell therapy (260)
Cervical cancer (7)
Clinical research (18677)
Collaboration (407)
Compensation (98)
Complete response letters (11)
COVID-19 (748)
CRISPR (17)
C-suite (133)
Cystic fibrosis (40)
Data (685)
Denatured (5)
Depression (19)
Diabetes (61)
Diagnostics (1077)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (63)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (40)
Earnings (15951)
Editorial (17)
Employer branding (8)
Employer resources (69)
Events (31353)
Executive appointments (343)
FDA (2645)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (351)
Gene editing (50)
Generative AI (12)
Gene therapy (178)
GLP-1 (268)
Government (630)
Grass and pollen (1)
Guidances (9)
Healthcare (2400)
Huntington's disease (18)
IgA nephropathy (12)
Immunology and inflammation (65)
Indications (11)
Infectious disease (804)
Inflammatory bowel disease (70)
Inflation Reduction Act (3)
Influenza (21)
Intellectual property (44)
Interviews (139)
IPO (4113)
IRA (13)
Job creations (1478)
Job search strategy (703)
Kidney cancer (4)
Labor market (23)
Layoffs (167)
Leadership (11)
Legal (1190)
Liver cancer (17)
Lung cancer (95)
Lymphoma (57)
Machine learning (2)
Management (23)
Manufacturing (137)
MASH (22)
Medical device (688)
Medtech (689)
Mergers & acquisitions (5466)
Metabolic disorders (224)
Multiple sclerosis (31)
NASH (8)
Neurodegenerative disease (47)
Neuropsychiatric disorders (13)
Neuroscience (650)
NextGen: Class of 2025 (1446)
Non-profit (453)
Northern California (878)
Now hiring (17)
Obesity (126)
Opinion (175)
Ovarian cancer (34)
Pain (29)
Pancreatic cancer (26)
Parkinson's disease (49)
Partnered (9)
Patents (73)
Patient recruitment (30)
Peanut (13)
People (22142)
Pharmaceutical (15)
Phase I (7257)
Phase II (8917)
Phase III (5021)
Pipeline (421)
Podcasts (30)
Policy (55)
Postmarket research (306)
Preclinical (2951)
Press Release (61)
Prostate cancer (29)
Psychedelics (18)
Radiopharmaceuticals (83)
Rare diseases (170)
Real estate (2441)
Recruiting (36)
Regulatory (4508)
Reports (20)
Research institute (516)
Resumes & cover letters (152)
RNA editing (2)
RSV (13)
Schizophrenia (23)
Series A (82)
Series B (44)
Service/supplier (6)
Sickle cell disease (22)
Southern California (822)
Special edition (10)
Spinal muscular atrophy (48)
Sponsored (11)
Startups (1782)
State (1)
Stomach cancer (5)
Supply chain (21)
The Weekly (25)
United States (7276)
Vaccines (224)
Venture capitalists (32)
Webinars (9)
Weight loss (88)
Women's health (9)
Worklife (7)
Date
Today (4)
Last 7 days (229)
Last 30 days (978)
Last 365 days (12319)
2025 (2963)
2024 (12666)
2023 (13202)
2022 (16044)
2021 (16931)
2020 (13184)
2019 (9503)
2018 (7544)
2017 (8978)
2016 (8114)
2015 (9409)
2014 (9727)
2013 (9450)
2012 (6081)
2011 (6461)
2010 (5852)
Location
Africa (325)
Alabama (27)
Alaska (3)
Arizona (46)
Arkansas (2)
Asia (13469)
Australia (2680)
California (2062)
Canada (672)
China (182)
Colorado (39)
Connecticut (83)
Delaware (36)
Europe (30186)
Florida (228)
Georgia (32)
Idaho (13)
Illinois (128)
India (10)
Indiana (104)
Iowa (3)
Japan (54)
Kansas (16)
Kentucky (4)
Louisiana (3)
Maine (2)
Maryland (316)
Massachusetts (1613)
Michigan (93)
Minnesota (118)
Missouri (16)
Montana (8)
Nebraska (4)
Nevada (8)
New Hampshire (7)
New Jersey (548)
New Mexico (11)
New York (531)
North Carolina (352)
North Dakota (4)
Northern California (878)
Ohio (55)
Oklahoma (7)
Oregon (8)
Pennsylvania (430)
Puerto Rico (3)
Rhode Island (8)
South America (400)
South Carolina (2)
Southern California (822)
Tennessee (19)
Texas (242)
Utah (29)
Virginia (14)
Washington D.C. (16)
Washington State (319)
Wisconsin (11)
183,428 Results for "portage biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
March 28, 2025
·
3 min read
Press Releases
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial
March 12, 2025
·
3 min read
Press Releases
Portage Biotech Announces Completion of $2.15 Million Private Financing
January 30, 2025
·
2 min read
Press Releases
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
February 13, 2025
·
2 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Pharm Country
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Portage Biotech Inc. reported that it has completed selling its equity holding in Intensity Therapeutics.
March 26, 2024
·
3 min read
Press Releases
Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company
January 6, 2025
·
4 min read
Press Releases
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
November 27, 2024
·
10 min read
Pharm Country
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused
Portage Biotech Inc. today reported that it is expanding its evaluation of strategic alternatives and implementing additional measures to extend its available cash runway.
April 12, 2024
·
3 min read
Drug Development
Portage Biotech Reports Business and Strategic Update
Portage Biotech Inc. today announced the outcome from the company’s comprehensive review of its pipeline in the context of the current capital raising market conditions.
January 4, 2024
·
4 min read
1 of 18,343
Next
